Skip to content

Drug interactions

Cladribine + Ofatumumab sc

Severity: Major

Cladribine and Ofatumumab sc: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs deplete lymphocytes, one by direct cytotoxicity and the other through B-cell depletion. Combined or sequential overlapping use increases the risk of prolonged immunosuppression and infection.

What this interaction means in plain words

Cladribine and Ofatumumab sc can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Additive immunosuppression via T- and B-lymphocyte depletion.

What to do

Avoid concurrent use and allow lymphocyte recovery when switching between them. Monitor lymphocyte counts and infection signs.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cladribine and Ofatumumab sc, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Cladribine with Ofatumumab sc?

MediHelp rates the interaction as major. Cladribine and Ofatumumab sc can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs deplete lymphocytes, one by direct cytotoxicity and the other through B-cell depletion. Combined or sequential overlapping use increases the risk of prolonged immunosuppression and infection.

How serious is the interaction between Cladribine and Ofatumumab sc?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use and allow lymphocyte recovery when switching between them. Monitor lymphocyte counts and infection signs.

What other medicines interact with Cladribine?

MediHelp also lists interactions of Cladribine with, for example, Adenovirus types 4 and 7 live, Siponimod, Tofacitinib. The full list is on the Cladribine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in